|
Atlas of Blood Cancer Genomes: Our 10,000 Patient Odyssey To Personalized Genomics |
01/18/2023 - 8:00am to 9:00am EST |
|
Breaking Bad B Cells: Identifying Novel Targets in Chronic GVHD |
01/04/2023 - 8:30am to 9:00am EST |
|
CAR T-Cell Therapy for Pediatric B-ALL |
05/17/2023 - 8:00am to 9:00am EDT |
|
Circulating Tumor DNA as a Non-Invasive Biomarker in Solid Tumor Oncology |
04/05/2023 - 8:00am to 9:00am EDT |
|
Developments in the Management of Early-Stage Resectable NSCLC without Targetable Mutations & An unusual case of lung cancer: MALT lymphoma in a young |
12/06/2023 - 8:00am to 9:00am EST |
|
Division of Hematologic Malignancies & Cellular Therapy Updates Part 1 |
09/13/2023 - 8:00am to 9:00am EDT |
|
Division of Hematologic Malignancies & Cellular Therapy Updates Part 2 |
09/20/2023 - 8:00am to 9:00am EDT |
|
Division of Medical Oncology Updates Part 1 |
10/04/2023 - 8:00am to 9:00am EDT |
|
Division of Medical Oncology Updates Part 2 |
10/11/2023 - 8:00am to 9:00am EDT |
|
DNA Damage Responses: Bedside to Bench to Bedside |
02/15/2023 - 8:00am to 9:00am EST |
Facebook
Twitter
LinkedIn
Forward